Search

everythinglearnresearchcommunity

for

Search:↓

Oral minoxidil and topical minoxidil 5% both effectively improve female-pattern hair loss with safe side effects.

PRP therapy improves hair density and thickness in AGA patients, even with other treatments.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Treatment with methotrexate and prednisolone led to complete hair regrowth and no relapse for 2 years.

Combining platelet-rich plasma and minoxidil can effectively regrow hair in severe alopecia areata cases.

A young man's hair loss was the only sign of syphilis, which improved after treatment.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Pruritus is common in LPP and FFA, worsened by heat and stress, and relieved by cold, affecting quality of life.

The treatment improved hair thickness, shine, and reduced hair loss effectively.

Americans see hair transplants as valuable for treating hair loss and want them to be more affordable and tailored to each gender.

Low-dose oral minoxidil effectively promotes hair growth but has associated risks.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

A 12-year-old boy's hair fully regrew after 8 weeks of treatment for tinea capitis, and dermoscopy was useful for diagnosis and monitoring.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Lower levels of certain genes in hair cells improve hair loss treatment outcomes.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

A dietary supplement with Boswellia serrata, Curcuma longa, and Vitis vinifera showed potential improvement in hair health for telogen effluvium patients, but more research is needed.

A new tool can analyze hair to detect changes due to hormones, genetics, and aging.

Researchers established normal hair and scalp characteristics for healthy women using trichoscopy.

Trichoscopy effectively diagnoses early female hair loss, but may need scalp biopsy for confirmation.

Intramuscular injections improved hair density more than intradermal injections for treating hair loss.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

Corticosteroid injections for hair loss may cause eye problems, so caution is needed.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.